Chandra, Shruti http://orcid.org/0000-0002-2634-9775
Gurudas, Sarega
Pearce, Ian
Mckibbin, Martin http://orcid.org/0000-0003-4388-243X
Kotagiri, Ajay
Menon, Geeta
Burton, Benjamin J. L. http://orcid.org/0000-0001-9579-9078
Talks, James
Grabowska, Anna http://orcid.org/0000-0002-3053-2142
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Gale, Richard
Giani, Andrea
Chong, Victor http://orcid.org/0000-0002-7693-522X
Chen, Ching Ning Taffeta
Nicholson, Luke
Thottarath, Sridevi
Chandak, Swati http://orcid.org/0000-0001-8255-6253
Sivaprasad, Sobha
Funding for this research was provided by:
Boehringer Ingelheim (SIVS 1045, SIVS1045)
Article History
Received: 11 August 2023
Revised: 20 November 2023
Accepted: 30 November 2023
First Online: 15 December 2023
Competing interests
: SSi reported receiving financial support from AbbVie, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Iveric Bio, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, OcuTerra, Roche. Victor Chong is an employee of Janssen R&D and previously of Boehringer Ingelheim. Andrea Giani is an employee of Boehringer Ingelheim. Chingning, Taffeta, Chen is an employee of Boehringer Ingelheim. Benjamin Burton has been on advisory boards and received international conference attendance sponsored by Novartis, Roche and Bayer. Geeta Menon has conducted consultancy-advisory boards for Novartis, Bayer and Allergan, received educational travel grants from Novartis, Bayer, Allergan. Ian Pearce has received lecture fees from Allergan, Bayer, Roche, Heidelberg and Novartis, consultancy fees from Allergan, Alimera, Bayer and Novartis and travel fees from Allergan, Bayer and Novartis. Faruque Ghanchi has received honorarium for consultancy-advisory boards from Alimera, Allergan, Bayer, Novartis, Oxford BioElectronics, Roche, educational travel grants from Allergan, Bayer, Novartis. Martin McKibbin has received lecture and advisory board honoraria from Bayer and Novartis and an educational travel grant from Bayer. Richard Gale has conducted consultancy-advisory boards for Novartis, Bayer, Biogen, Boehringer Ingelheim and Allergan, Alimera, Santen, received educational travel grants from Novartis, Bayer, Allergan, Heidelberg Engineering. James Talks is a consultant for Bayer and Roche, received grant support from Bayer, Novartis and Heidelberg Engineering, and is involved in research for Allergan, Alimera, Roche, Bayer, Novartis and Boehringer-Ingelheim. AK received travel support from Novartis, Bayer, and Allergan, and speaker fees from Allergan and Bayer. LN received advisory boards honoraria from Roche, Abbvie and Bayer. SS, SC, and FG. Are on the Editorial board for Eye.